Abstract:Introduction Alzheimer's disease (AD) stands as the most prevalent form of dementia. Alzheimer's Disease is acknowledged to have a complex origin, a gradual neurodegenerative progression, and a wide-ranging clinical profile marked primarily by progressive memory loss, cognitive decline, and various functional impairments that significantly diminish the quality of life: Key characteristics of AD encompass the presence of amyloid plaques, which are characterized by the pathological accumulation of insoluble β-amyloid (Aβ) aggregates within the brain tissue and blood vessel walls.Several reports have indicated the existence of cerebral abnormalities within platelets in individuals afflicted by AD. Objectives The objective of this investigation was to review studies investigating the metabolism of APP in platelets among individuals with AD to identify potential dependable peripheral indicators leading to novel approaches to its management and treatment. Methods A systematic review according to the PRISMA guidelines was carried out, by accessing the PubMed database up to June 2023. The authors screened the titles and the abstracts of all the potentially relevant papers on the basis of a strict list of exclusion and inclusion criteria. Results A total of thirty-two studies were included. The evidence points towards the observation that AD individuals exhibit various modifications in platelet APP processing when compared to matched healthy controls, that are frequently associated with the severity of cognitive impairment and functional independence. The majority of the evidence supports changes in platelet ADAM-10 activity, β-secretase activity, APP ratio, a state of heightened platelet activation or hyper-responsiveness, and a potential release of platelet APP via vesicular mechanisms, which may ultimately contribute to Aβ production. Conclusions Platelets offer a promising peripheral model for detecting and evaluating molecular changes associated with AD, as they hold the potential to provide vital insights into the development of an effective diagnostic tool and open doors to innovative therapeutic approaches. Disclosure of Interest None Declared

One immune cell to bind them all: platelet contribution to neurodegenerative disease

Contribution of blood platelets to vascular pathology in Alzheimer's disease.

The possible role of platelet APP processing in the pathophysiology of Alzheimer's Disease

Potential links between platelets and amyloid-β in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies

Alternative platelet activation pathways and their role in neurodegenerative diseases

Current Knowledge and Future Perspectives

Structural biology of cell surface receptors implicated in Alzheimer’s disease

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease

Insights into the Neurodegenerative Process of Alzheimer's Disease: a Role for Mononuclear Phagocyte-Associated Inflammation and Neurotoxicity

Platelets transport β-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer's disease in mouse models

Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

Inflammatory aspects of Alzheimer's disease

Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease

Platelets, a Key Cell in Inflammation and Atherosclerosis Progression

The platelet transcriptome and proteome in Alzheimer's disease and aging: an exploratory cross-sectional study

Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies

Neutrophils as a potential therapeutic target in Alzheimer's disease

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells